Suppr超能文献

聚砜/聚醚砜透析器的急性反应:文献综述与处理

Acute reactions to polysulfone/polyethersulfone dialysers: literature review and management.

作者信息

Boer W H, Liem Y, de Beus E, Abrahams A C

机构信息

Department of Nephrology, University Medical Center, Utrecht, the Netherlands.

出版信息

Neth J Med. 2017 Jan;75(1):4-13.

Abstract

Acute dialyser reactions in patients treated by haemodialysis are uncommon. We present two cases of such reactions, both in patients using a polysulfone, steam-sterilised dialyser. Patient 1 suffered from recurrent attacks of acute dyspnoea, hypoxia and hypotension that occurred early in dialysis sessions, whereas patient 2 presented with unexplained episodes of severe hypotension and vomiting in the initial phases of dialysis. After switching to a cellulose triacetate dialyser, both patients became asymptomatic during all subsequent dialysis sessions, but intentional (patient 1) and accidental (patient 2) rechallenge with the polysulfone dialyser induced an immediate recurrence of the symptoms. A literature search yielded 30 additional cases that have been reported since the turn of the century. All dialysers that provoked acute reactions contained membranes belonging to the polyarylsulfone family (polysulfone/polyethersulfone, PSu/PESu). Manifestations, usually occurring within the first 30 minutes of dialysis, included dyspnoea (69%), hypotension (66%), hypoxia (44%), bronchospasm (25%), chest pain (22%), pruritus and/or urticaria (22%) and abdominal symptoms (22%). Of the 32 patients, 14 were switched to a different PSu/PESu containing dialyser, which resulted in cross-reactivity in 12 of them (~85%). They could be treated safely with dialysers containing substituted cellulose (n = 8) or polyacrylonitrile (n = 4). Sixteen patients were successfully switched directly to a dialyser containing substituted cellulose (n = 11), polymethylmethacrylate (n = 4) or polyacrylonitrile (n = 1). Two patients were lost to follow-up. As rechallenges may be harmful, patients with acute reactions to PSu/PESu membranes should not be further tested in a trial-and-error fashion with similar membranes, but be switched directly to a non-PSu/PESu dialyser.

摘要

接受血液透析治疗的患者发生急性透析器反应并不常见。我们报告了两例此类反应,均发生在使用经蒸汽消毒的聚砜透析器的患者身上。患者1在透析过程早期反复出现急性呼吸困难、低氧血症和低血压,而患者2在透析初始阶段出现不明原因的严重低血压和呕吐发作。改用醋酸纤维素透析器后,两名患者在随后的所有透析过程中均无症状,但患者1故意再次使用聚砜透析器以及患者2意外再次使用该透析器后,症状立即复发。文献检索发现自世纪之交以来又有30例相关病例报告。所有引发急性反应的透析器均含有聚芳基砜家族的膜(聚砜/聚醚砜,PSu/PESu)。症状通常在透析的前30分钟内出现,包括呼吸困难(69%)、低血压(66%)、低氧血症(44%)、支气管痉挛(25%)、胸痛(22%)、瘙痒和/或荨麻疹(22%)以及腹部症状(22%)。在这32例患者中,14例改用了另一种含PSu/PESu的透析器,其中12例(约85%)出现交叉反应。使用含取代纤维素(n = 8)或聚丙烯腈(n = 4)的透析器可对他们进行安全治疗。16例患者成功直接改用含取代纤维素(n = 11)、聚甲基丙烯酸甲酯(n = 4)或聚丙烯腈(n = 1)的透析器。两名患者失访。由于再次使用可能有害,对PSu/PESu膜有急性反应的患者不应再以试错方式用类似膜进行进一步检测,而应直接改用非PSu/PESu透析器。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验